- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Lunar reports higher sales, profits
Lunar continues to post improvingfinancial numbers. The Madison, WI, company last month reportedsharply higher results for the third quarter of 1994 (end-March). Total revenues for the quarter increased 21%, to $8 millionfrom $6.6 million in the same
Lunar continues to post improvingfinancial numbers. The Madison, WI, company last month reportedsharply higher results for the third quarter of 1994 (end-March).
Total revenues for the quarter increased 21%, to $8 millionfrom $6.6 million in the same period the year before. Net incomefor the quarter jumped 73%, to $2 million compared to $1.2 millionin the second quarter of 1993. The jump in Lunar's financial resultsis due to strong sales of its Achilles line, according to thecompany.
While Achilles is surging, Lunar reported that it has experienceddelays in finalizing the system integration of hardware and softwarefor its Expert high-end bone densitometry system. While severalbeta sites have been successfully installed, the company doesnot expect extensive shipments of Expert during the current fiscalyear.
Lunar is also the exclusive North American distributor forEsaote Biomedica's Artoscan niche MRI system.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
